Lombardi, Carlo Mario
 Distribuzione geografica
Continente #
NA - Nord America 11.848
AS - Asia 6.861
EU - Europa 5.965
SA - Sud America 1.390
AF - Africa 123
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 8
Totale 26.218
Nazione #
US - Stati Uniti d'America 11.619
SG - Singapore 2.320
CN - Cina 2.303
UA - Ucraina 1.282
BR - Brasile 1.191
PL - Polonia 1.087
HK - Hong Kong 881
DE - Germania 860
IT - Italia 820
FI - Finlandia 443
VN - Vietnam 396
GB - Regno Unito 347
RU - Federazione Russa 305
TR - Turchia 295
IN - India 275
IE - Irlanda 257
FR - Francia 191
CA - Canada 107
SE - Svezia 106
BD - Bangladesh 104
AR - Argentina 77
MX - Messico 75
JP - Giappone 52
NL - Olanda 52
ZA - Sudafrica 45
ES - Italia 40
BE - Belgio 37
IQ - Iraq 37
CZ - Repubblica Ceca 36
SA - Arabia Saudita 33
EC - Ecuador 30
ID - Indonesia 29
AT - Austria 25
PK - Pakistan 24
CO - Colombia 23
AU - Australia 19
MA - Marocco 19
VE - Venezuela 18
LT - Lituania 16
AE - Emirati Arabi Uniti 14
TN - Tunisia 14
JM - Giamaica 13
PY - Paraguay 13
JO - Giordania 12
KE - Kenya 12
CL - Cile 11
BG - Bulgaria 10
EG - Egitto 10
UY - Uruguay 10
NP - Nepal 8
PA - Panama 8
PE - Perù 8
BO - Bolivia 7
DZ - Algeria 7
HN - Honduras 7
KZ - Kazakistan 7
LV - Lettonia 7
TH - Thailandia 7
UZ - Uzbekistan 7
AL - Albania 6
DO - Repubblica Dominicana 6
EU - Europa 6
HU - Ungheria 6
IR - Iran 6
MU - Mauritius 6
IL - Israele 5
MY - Malesia 5
OM - Oman 5
PH - Filippine 5
RO - Romania 5
AZ - Azerbaigian 4
CH - Svizzera 4
ET - Etiopia 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
TT - Trinidad e Tobago 4
KR - Corea 3
LK - Sri Lanka 3
MD - Moldavia 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PS - Palestinian Territory 2
SI - Slovenia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
Totale 26.204
Città #
Fairfield 1.244
Ashburn 1.080
Warsaw 1.077
Singapore 1.019
Jacksonville 921
Hong Kong 880
Woodbridge 792
Chandler 628
Beijing 624
Houston 599
Seattle 538
Cambridge 521
Wilmington 504
Ann Arbor 481
Princeton 447
New York 345
Nanjing 313
Los Angeles 271
Helsinki 270
Dublin 256
Istanbul 242
Munich 168
The Dalles 157
Dallas 140
Ho Chi Minh City 126
Moscow 119
Buffalo 112
São Paulo 112
Milan 110
Pune 108
Redondo Beach 102
Nanchang 100
Des Moines 97
Brescia 96
Changsha 95
Shenyang 90
San Francisco 89
San Diego 86
Dearborn 85
Shanghai 83
Chicago 79
Hebei 78
Hanoi 77
Tianjin 71
London 69
Jinan 60
Jiaxing 57
Tokyo 50
Frankfurt am Main 49
Brooklyn 46
Turku 45
Montreal 43
Rome 42
Santa Clara 40
Romola 39
Rio de Janeiro 38
Guangzhou 36
Nuremberg 36
Boston 35
Brussels 35
Dong Ket 34
Kocaeli 34
Kunming 34
Lancaster 33
Poplar 32
Stockholm 32
Hangzhou 31
Brno 30
Chennai 29
Phoenix 28
Düsseldorf 27
Toronto 27
Verona 27
Mexico City 26
Ningbo 26
Zhengzhou 26
Charlotte 25
Johannesburg 22
Atlanta 21
Denver 21
Haikou 21
Taizhou 20
Belo Horizonte 19
Washington 18
Brasília 17
Dhaka 17
Orange 17
Orem 17
Amsterdam 16
Curitiba 16
Da Nang 16
Guarulhos 16
Haiphong 16
Manchester 16
Boardman 15
Lanzhou 15
Mumbai 15
Riyadh 15
Campinas 14
Council Bluffs 14
Totale 17.047
Nome #
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 300
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 272
Can we improve the treatment of congestion in heart failure? 270
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 255
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 250
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 247
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 244
May 2020 at a glance: ischaemic heart failure and sex-related differences 231
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 218
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 191
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 189
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 187
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 183
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 178
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 175
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 172
Amino acids and derivatives, a new treatment of chronic heart failure? 171
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 162
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 162
Can we prevent or treat renal dysfunction in acute heart failure? 158
Neurohormonal activation in acute heart failure: results from VERITAS 155
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 155
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 147
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 145
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 144
Anemia and heart failure : a cause of progression or only a consequence? 143
A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure 143
Prognostic value of the absolute lymphocyte count in patients admitted for acute heart failure 143
Serelaxin a novel treatment for acute heart failure 142
N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure 142
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 136
Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health 136
The management of acute heart failure. 135
N-3 PUFA increase bioavailability and function of endothelial progenitor cells 135
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 135
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 133
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 132
The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy 132
Heart failure and anemia: Effects on prognostic variables 131
Prognostic Evaluation Of The Ascending Aorta's Elastic Properties In Patients With Non-Ischemic Dilated Cardiomyopathy: An Echocardiographic Long-Term Follow-Up Study. 130
Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. 128
Nutritional Deficiency in Patients with Heart Failure. 127
The Additional Role Of Diabetes Mellitus On Hypertension-Related Aortic Stiffness. 127
Assessment of Congestion in Acute Heart Failure: When Simplicity Does Not Go Along With Accuracy 127
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 125
Six-year prognosis of diabetic patients with coronary artery disease. 125
Echocardiographic elastic properties of ascending aorta and their relationship with exercise capacity in patients with non-ischemic dilated cardiomyopathy 125
Updates in heart failure: what last year brought to us 125
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. 123
Red cell distribution width and chronic heart failure: prognostic role beyond echocardiographic parameters. 123
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 123
Significato prognostico indipendente della frequenza cardiaca a riposo alla dimissione come predittore di mortalità in pazienti ricoverati per insufficienza cardiaca acuta. 120
Iron deficiency in heart failure 120
The need for evaluating right ventricular adaptation and ventriculo–arterial coupling 119
Apnee notturne e insufficienza cardiaca: un problema in via di soluzione. 118
Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure 118
Preoperative cardiac risks in noncardiac surgery: The role of coronary angiography 118
Body Mass Index Paradox In Acute Herat Failure 118
Arterial Stiffness And Ventricular-Arterial Coupling In Hfref. 118
Role of fluid retention in patients hospitalised for acute heart failure. 117
In-hospital worsening heart failure in patients admitted for acute heart failure 117
Acute heart failure 116
Novel insight into the dangerous connection between diabetes and heart failure 116
Exercise performance is a prognostic indicator in elderly patients with chronic heart failure: Application of metabolic exercise cardiac kidney indexes score 116
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. 115
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. 115
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms. 115
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study 115
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 114
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis 114
Valore prognostico delle variazioni dell'indice di distribuzione dei volumi eritrocitari (RDW) nello scompenso cardiaco cronico. 112
Acute heart failure: More questions than answers 112
Effect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome 111
Cardiorenal Interactions 111
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: early in vivo cardiovascular effects 111
Endomyocardial fibrosis and myocardial infarction leading to diastolic and systolic dysfunction requiring transplantation 111
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 110
Prediction of 1-year outcomes after an acute heart failure hospitalisation: importance of variables measured at the time of discharge. 109
Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis 109
Acute heart failure: The heart failure patient's journey-the vulnerable phase: Bibliography of one hundred key papers 109
School and family-based interventions for promoting a healthy lifestyle among children and adolescents in Italy: A systematic review 109
Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure 108
Is there a role for ivabradine beyond its conventional use? 108
Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? 108
Treatment of Patients Recently Admitted for Acute Heart Failure Based on NT-proBNP Plasma Levels Measurements. Results of a Prospective, Randomized, Single-centre Trial 106
Mode of death and hospitalization from the second follow-up serial infusions of nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes 106
La terapia con inotropi del paziente con insufficienza cardiaca: oltre i farmaci tradizionali 104
Clinical characteristics and outcome of acute heart failure patients with mid-range ejection fraction. 104
September 2019 at a glance: focus on devices 104
Carnosine: Potential aid for diabetes and cardiovascular disease 103
Decongestion, Arterial Stiffness And Ventricular-Arterial Coupling In Ahf. 103
Le pressioni di riempimento ventricolari e la risposta ventilatoria allo sforzo identificano i pazienti con insufficienza cardiaca ad alto rischio di eventi nonostante la terapia beta-bloccante. 102
Beta 2 adrenergic receptors polymorphism influence: the effects of carvedinol in the patients with cronic heart failure. 102
Effect of bosentan on exercise capacity and clinical worsening in patients with dual Down and Eisenmenger syndrome 102
Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial 102
Early readmission for heart failure: An avoidable or ineluctable debacle? 102
Amino acid supplementation in patients with heart failure 100
Dobutamine stress echocardiography in pulmonary arterial hypertension 100
Prognostic value of blood urea nitrose and its changes in patients with chronic heart failure. 99
January 2020 at a glance: translational medicine, predictors of outcome and treatments 99
Totale 13.782
Categoria #
all - tutte 142.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.984 0 0 0 0 0 382 98 368 358 367 262 149
2021/20221.621 72 245 42 119 48 77 42 142 80 197 166 391
2022/20231.749 262 92 27 125 168 468 5 165 274 14 84 65
2023/20242.064 124 32 210 172 123 422 92 77 410 50 47 305
2024/20254.656 46 60 76 534 461 388 511 238 406 370 943 623
2025/20265.753 1.032 1.365 746 1.423 1.026 161 0 0 0 0 0 0
Totale 26.601